Table of Contents
What is capecitabine drug used for?
Capecitabine is used to help treat patients with Dukes’ C colon cancer (colon cancer that has spread to lymph nodes in the area close to the colon), after having surgery. This medicine is also used to treat metastatic colorectal cancer (cancer of the colon or rectum that has spread to other parts of the body).
What are the side effects of capecitabine 500mg?
Nausea, vomiting, loss of appetite, constipation, tiredness, weakness, headache, dizziness, trouble sleeping, or changes in taste may occur. Nausea and vomiting can be severe. In some cases, your doctor may prescribe medication to prevent or relieve nausea and vomiting.
How long before chemo shrinks a tumor?
In general, chemotherapy can take about 3 to 6 months to complete. It may take more or less time, depending on the type of chemo and the stage of your condition. It’s also broken down into cycles, which last 2 to 6 weeks each.
What is CAP 500 pill used for?
CAP 500 (Capecitabine 500 mg) Pill with imprint CAP 500 is Pink, Capsule-shape and has been identified as Capecitabine 500 mg. It is supplied by Shilpa Medicare Limited. Capecitabine is used in the treatment of breast cancer, metastatic; colorectal cancer; breast cancer; anal cancer (and ), and belongs to the drug class antimetabolites.
How many milligrams of capecitabine are in a film coated tablet?
Each film-coated tablet contains 500 mg of capecitabine Excipient with known effect: Each film-coated tablets contains 25.470 mg anhydrous lactose For the full list of excipients, see section 6.1.
What is the role of capecitabine in the treatment of gastric cancer?
Capecitabine has also been used in combination with oxaliplatin for the treatment of advanced gastric cancer. Studies with capecitabine monotherapy indicate that capecitabine has activity in advanced gastric cancer.
How do you take capecitabine tablets?
Capecitabine tablets should be swallowed whole with water within 30 minutes after a meal. Capecitabine tablets should not be crushed or cut. • History of severe and unexpected reactions to fluoropyrimidine therapy • Hypersensitivity to capecitabine or to any of the excipients listed in section 6.1 or fluorouracil